Article
The complexities of TGF-β action during mammary and squamous cell carcinogenesis.
Current pharmaceutical biotechnology - 1 Dec 2011
Connolly Erin C, Akhurst Rosemary J
Abstract excerpt
Many advanced tumors produce excess amounts of Transforming Growth Factor-β (TGF-β), which is a potent growth inhibitor of normal epithelial cells. However, in tumors its homeostatic action on cells can be diverted along several alternative pathways. Thus, TGF-β signaling has been reported to elicit a preventative or tumor suppressive effect during the earlier stages of tumorigenesis, but later in tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
